MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.04MP/E –Yield –
MiMedx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
MiMedx's pe ratio was 83.0× on Nov 11, 2026, against 25.5× a year earlier. Over the last 5 years it ranged from 7.9× to 235.3×, with a median of 22.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 83.0× | +57.9 |
| 2025 | Dec 31, 2025 | 25.1× | +9.1 |
| 2024 | Dec 31, 2024 | 16.0× | −219.3 |
| 2023 | Dec 29, 2023 | 235.3× | +209.0 |
| 2019 | Jan 31, 2019 | 26.4× | +8.5 |
| 2018 | Dec 31, 2018 | 17.9× | −4.6 |
| 2017 | Dec 29, 2017 | 22.5× | −29.6 |
| 2016 | Dec 30, 2016 | 52.1× | +0.1 |
| 2015 | Dec 31, 2015 | 52.1× | – |
See a number that looks wrong?